While NRG1β induces significant phosphorylation of EGFR, ASPN activation of EGFR is limited, suggesting that ASPN-induced ErbB signaling in prostate cancer is primarily through HER2 and HER3. This evidence concerns the gene ERBB2 and prostate carcinoma.